Delay discounting, treatment motivation and treatment retention among substance-dependent individuals attending an in inpatient detoxification program

Journal of Substance Abuse Treatment

Volumn 49, Issue , 2015, Pages 58-64

  Stevens, Laura ^a   Verdejo García, Antonio ^b,c   Roeyers, Herbert ^a   Goudriaan, Anna E ^d,e   Vanderplasschen, Wouter ^a  

^a GHENT UNIVERSITY   (Belgium)

^b UNIVERSITY OF GRANADA   (Spain)

^c MONASH UNIVERSITY   (Australia)

^d UNIVERSITY OF AMSTERDAM   (Netherlands)

^e Arkin Mental Health Care   (Netherlands)

Author keywords

Delay discounting; Impulsivity; Motivation; Treatment readiness; Treatment retention

Indexed keywords

CANNABIS; COCAINE; OPIATE;

ADULT; ARTICLE; DELAY DISCOUNTING; DETOXIFICATION; DRUG USE; EDUCATIONAL STATUS; HEALTH PROGRAM; HUMAN; INTELLIGENCE QUOTIENT; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MOTIVATION; SUBSTANCE ABUSE; TREATMENT DURATION; FEMALE; HOSPITAL PATIENT; PATIENT ATTITUDE; PATIENT COMPLIANCE; PHYSIOLOGY; PSYCHOLOGY; SUBSTANCE-RELATED DISORDERS;

ADULT; DELAY DISCOUNTING; FEMALE; HUMANS; INPATIENTS; MALE; MOTIVATION; PATIENT ACCEPTANCE OF HEALTH CARE; PATIENT COMPLIANCE; SUBSTANCE-RELATED DISORDERS;

EID: 84920366100     PISSN: 07405472     EISSN: 18736483     Source Type: Journal    
DOI: 10.1016/j.jsat.2014.08.007     Document Type: Article

References (50)

1. American Psychiatric Association Diagnostic and statistical manual of mental disorders: DSM-IV 1994, Author, Washington, DC. 4th ed.
2. Ball S.A., Carroll K.M., Canning-Ball M., Rounsaville B.J. Reasons for dropout from drug abuse treatment: Symptoms, personality, and motivation. Addictive Behaviors 2006, 31:320-330.
3. Bates M.E., Buckman J.F., Nguyen T.T. A role for cognitive rehabilitation in increasing the effectiveness of treatment for alcohol use disorders. Neuropsychology Review 2013, 23:27-47.
4. Bechara A. Decision making, impulse control and loss of willpower to resist drugs: A neurocognitive perspective. Nature Neuroscience 2005, 8:1458-1463.
5. Bickel W.K., Yi R., Kowal B.P., Gatchalian K.M. Cigarette smokers discount past and future rewards symmetrically and more than controls: Is discounting a measure of impulsivity?. Drug and Alcohol Dependence 2008, 96:256-262.
6. Bickel W.K., Yi R., Landes R.D., Hill P.F., Baxter C. Remember the future: Working memory training decreases delay discounting among stimulant addicts. Biological Psychiatry 2011, 69:260-265.
7. Bjork J.M., Hommer D.W., Grant S.J., Danube C. Impulsivity in abstinent alcohol-dependent patients: Relation to control subjects and type 1-/type 2 like traits. Alcoholism 2004, 34:133-150.
8. Blume A.W., Marlatt G.A., Schmaling K.B. Executive cognitive function and heavy drinking behavior among college students. Psychology of Addictive Behaviors 2000, 14:299-302.
9. Blume A.W., Schmaling K.B., Marlatt G.A. Memory, executive cognitive function, and readiness to change drinking behavior. Addictive Behaviors 2005, 30:301-314.
10. Brewer D.D., Catalano R.F., Haggerty K., Gainey R.R., Fleming C.B. A meta-analysis of predictors of continued drug use during and after treatment for opiate addiction. Addiction 1998, 93:73-92.
11. Brorson H.H., Ajo Arnevik E., Rand-Hendriksen K., Duckert F. Drop-out from addiction treatment: A systematic review of risk factors. Clinical Psychology Review 2013, 33(8):1010-1024.
12. Businelle M.S., McVay M.A., Kendzor D., Copeland A. A comparison of delay discounting among smokers, substance abusers, and non-dependent controls. Drug and Alcohol Dependence 2010, 112:247-250.
13. Coffey S.F., Gudleski G.D., Saladin M.E., Brady K.T. Impulsivity and rapid discounting of delayed hypothetical rewards in cocaine-dependent individuals. Experimental and Clinical Psychopharmacology 2003, 11:18-25.
14. De Weert-Van Oene G.H., Schippers G.M., De Jong C.A.J., Schrijvers G.A. Motivation for treatment in substance-dependent patients. Psychometric evaluation of the TCU motivation for treatment scales. European Addiction Research 2002, 8(1):2-9.
15. De Wilde B., Verdejo-Garcia A., Sabbe B., Hulstijn W., Dom G. Affective decision-making is predictive of three-month relapse in polysubstance-dependent alcoholics. European Addiction Research 2013, 19:21-28.
16. Evenden J. Impulsivity: A discussion of clinical and experimental findings. Journal of Psychopharmacology 1999, 13:180-192.
17. Garcia-Rodriguez O., Secades-Villa R., Higgins S.T., Fernandez-Hermida J.R., Carballo J.L., Errasti Perez J.M., et al. Effects of voucher-based intervention on abstinence and retention in an outpatient treatment for cocaine addiction: A randomized controlled trial. Experimental and Clinical Psychopharmacology 2009, 17:131-138.
18. Hayes A.F. PROCESS: A versatile computational tool for observed variable mediation, moderation, and conditional process modeling [White paper] 2012, (Retrieved from http://www.afhayes.com/public/process2012.pdf).
19. Heil S.H.T., Johnson M.W., Higgins S.T., Bickel W.K. Delay discounting in currently using and currently abstinent cocaine-dependent outpatients and non-drug-using matched controls. Addictive Behaviors 2006, 31:1290-1294.
20. Higgins S.T., Badger G.J., Budney A.J. Initial abstinence and success in achieving longer term cocaine abstinence. Experimental and Clinical Psychopharmacology 2000, 8:377-386.
21. Joe G.W., Simpson D.D., Broome K.M. Effects of readiness for drug abuse treatment on client retention and assessment of process. Addiction 1998, 93:1177-1190.
22. Kirby K.N., Petry N.M. Heroin and cocaine abusers have higher discount rates for delayed rewards than alcoholics or non-drug-using controls. Addiction 2004, 99:461-471.
23. LeBerre A.P., Vabret F., Cauvin C., Pinon K., Allain P., Pitel A.L., et al. Cognitive barriers to readiness to change in alcohol-dependent patients. Alcoholism, Clinical and Experimental Research 2012, 36:1542-1549.
24. MacKinnon D.P. Introduction to statistical mediation analysis 2008, Erlbaum, New York.
25. McClure S.M., Laibson D.I., Loewenstein G., Cohen J.D. Separate neural systems value immediate and delayed monetary rewards. Science 2004, 306:503-507.
26. McKay J.R., Hiller-Sturmhofel S. Treating alcoholism as a chronic disease. Alcohol Research and Health 2011, 33(4):356-370.
27. McLellan A.T., Luborsky L., Woody G.E., O'Brien C.P. An improved diagnostic evaluation instrument for substance abuse patients. The Addiction Severity Index. Journal of Nervous and Mental Disease 1980, 168(1):26-33.
28. Meier P., Donmall M.C., McElduff P., Barrowclough C., Heller R. The role of the early therapeutic alliance in predicting drug treatment dropout. Drug and Alcohol Dependence 2006, 83(1):57-64.
29. Miller W.R., Rollnick S. Motivational interviewing: Preparing people to change addictive behavior 1991, Guilford Press, New York.
30. Millery M., Kleinman B.P., Polissar N.L., Millman R.B., Scimeca M. Detoxification as a gateway to long-term treatment: Assessing two interventions. Journal of Substance Abuse Treatment 2002, 23(3):183-190.
31. Moeller F.G., Dougherty D.M., Barratt E.S., Schmitz J.M., Swann A.C., Grabowski J. The impact of impulsivity on cocaine use and retention in treatment. Journal of Substance Abuse Treatment 2001, 21:193-198.
32. Passetti F., Clark L., Davis P., Mehta M.A., White S., Checinski K., et al. Risky decision-making predicts short-term outcome of community but not residential treatment for opiate addiction. Implications for case management. Drug and Alcohol Dependence 2011, 118:12-18.
33. Passetti F., Clark L., Mehta M.A., Joyce E., King M. Neuropsychological predictors of clinical outcome in opiate addiction. Drug and Alcohol Dependence 2008, 94:82-91.
34. Peters E.N., Petry N.M., Lapaglia D.M., Reynolds B., Carroll K.M. Delay discounting in adults receiving treatment for marijuana dependence. Experimental and Clinical Psychopharmacology 2013, 21:46-54.
35. Prochaska J.O., DiClemente C.C. Transtheoretical therapy: Toward a more integrative model of change. Psychotherapy Theory Research and Practice 1982, 19:276-288.
36. Raes V., Lombaert G., Keymeulen R. De Nederlandse vertaling van de handleiding voor training en afname van Europ-asi vraaggesprekken, aangepast voor België-Vlaanderen, met integratie van de Treatment Demand Indicator 2008, De Sleutel Dienst Wetenschappelijk Onderzoek, Gent.
37. Rapp R.C., Xu J., Carr C.A., Lane D.T., Redko C., Wang J., et al. Understanding treatment readiness in recently assessed, pre-treatment substance abusers. Substance Abuse 2007, 28(1):11-23.
38. Richards J., Zhang L., Mitchell S.H., De Wit H. Delay and probability discounting in a model of impulsive behaviour: Effect of alcohol. Journal of the Experimental Analysis of Behavior 1999, 1:121-143.
39. Ringe W.K., Saine K.C., Lacritz L.H., Hynan L.S., Cullum C.M. Dyadic short forms of the Wechsler Adult Intelligence Scale-III. Assessment 2002, 9(3):254-260.
40. Severtson S.G., von Thomsen S., Hedden S.L., Latimer W. The association between executive functioning and motivation to enter treatment among regular users of heroin and/or cocaine in Baltimore, MD. Addictive Behaviors 2010, 35:717-720.
41. Sheehan D.V., Lecrubier Y., Sheehan K.H., Amorim P., Janavs J., Weiller E., et al. The Mini-International Neuropsychiatric Interview (M.I.N.I.): The development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. Journal of Clinical Psychiatry 1998, 59:22-33.
42. Simpson D.D., Joe G.W. Motivation as a predictor of early dropout from drug abuse treatment. Psychotherapy 1993, 30:357-368.
43. Stevens L., Verdejo-Garcia A., Goudriaan A.E., Roeyers H., Dom G., Vanderplasschen W. Impulsivity as a vulnerability factor for poor addiction treatment outcomes: A review of neurocognitive findings among individuals with substance use disorders. Journal of Substance Abuse Treatment 2014, 47(1):58-72.
44. Streeter C.C., Terhune D.B., Whitfield T.H., Gruber S., Sarid-Segal O., Silveri M.M., et al. Performance on the Stroop predicts treatment compliance in cocaine dependent individuals. Neuropsychopharmacology 2008, 33:827-836.
45. Vassileva J., Georgiev S., Martin E., Gonzalez R., Segala L. Psychopathic heroin addicts are not uniformly impaired across neurocognitive domains of impulsivity. Drug and Alcohol Dependence 2011, 114:194-200.
46. Washio Y., Higgins S.T., Heil S.H., McKerchar T.L., Badger G.J., Skelly J.M., et al. Delay discounting is associated with treatment response among cocaine dependent outpatients. Experimental and Clinical Psychopharmacology 2011, 19:243-248.
47. Wechsler D. WAIS-III administration and scoring manual 1997, The Psychological Corporation, San Antonio, TX.
48. Wechsler D. WAIS-III Nederlandstalige bewerking. Technische handleiding. WAIS-III, Dutch version manual 2000, Swets & Zeitlinger, Lisse (NL).
49. Wittmann M., Leland D.S., Paulus M.P. Time and decision making: Differential contribution of the posterior insular cortex and the striatum during a delay discounting task. Experimental Brain Research 2007, 179:643-653.
50. Zhang Z., Friedmann P.D., Gerstein D.R. Does retention matter? Treatment duration and improvement in drug use. Addiction 2003, 98:673-684.